ChemQuest Group appoints Sudhir Hublikar as Director
Dr. Hublikar is well known for his strong business acumen delivering profitable, sustained growth through innovation.
Broad technical experience
In his new role at ChemQuest, Dr. Hublikar will leverage his broad technical experience in fibers, plastics, adhesives, coatings and composites to assist clients in diverse markets ranging from aerospace & defense, to building envelope, civil engineering & construction as well as the industrial sector and textiles industry.
“We are excited to welcome Dr. Hublikar to our practice,” said Dan Murad, president/CEO of ChemQuest. “We feel confident that Sudhir can advance our clients’ profitability through his growth-oriented strategic approach to innovation for fibers, plastics, adhesives, coatings and composites. Moreover, Dr. Hublikar’s innovation methodology is a natural entrée into ChemQuest’s four pillars of service: business strategy, technology & development, buy-side advisory services in M&A (investment thesis through integration) and manufacturing, commercial & operational efficiencies.”
About Sudhir Hublikar
Dr. Hublikar earned a Ph.D. in Polymer Science and an MBA. His career, spanning thirty years, includes Technology R&D executive positions with BF Goodrich Aerospace, Noveon and AGY Holding Corporation, with his most recent position held at Avery Dennison Corporation. Just prior to joining ChemQuest, he, then-Vice President of Adhesives and Coatings R&D for Avery Dennison, led the creation of multiple disruptive technology platforms (some commercialised in 2016), with growth potential exceeding EUR95 million.
Solving complex problems
Joining the ChemQuest practice, Sudhir said, “I am excited to be putting 30-years of managing technological innovation in specialty chemicals to work for The ChemQuest Group, Inc. I look forward to my R&D executive role on behalf of ChemQuest clients, with seamless technical support executed through the ChemQuest Technology Institute, as an important differentiator for solving complex problems in chemicals’ business strategy.”